HOME >> MEDICINE >> NEWS
Oral formulation of antipsychotic offers 'user-friendly' alternative to injections for patients with acute psychosis

[11 September 2000, Munich] -- Although many physicians rely on intramuscular injections of antipsychotic drugs to treat patients who need emergency treatment for psychotic agitation, new research has found that the oral-solution form of Risperdal™ (risperidone) is just as effective and may be a more acceptable alternative for both caregivers and patients(1).

The study, which was presented today at a major international neuropsychopharmacology congress in Munich, found that Risperdal works as quickly and is as effective in reducing symptoms of psychotic agitation as an intramuscular (IM) injection of haloperidol, an older, conventional antipsychotic. Both medications were administered in combination with the antianxiety drug lorazepam.

"When there are two drugs that are equally efficacious, a physician's next consideration when selecting an antipsychotic drug in emergency situations should be patient choice and compliance," said Dr Glenn Currier, lead investigator and assistant professor of the departments of psychiatry and emergency medicine at the University of Rochester. "When patients experiencing psychotic agitation -- usually due to schizophrenia -- end up in the emergency room, they often are confused, scared and paranoid. Injections are painful, and can be perceived as hostile and 'coercive.' This can be a significant barrier to the physician's ability to deliver good care, and to the patient's ability to accept it."

In contrast, an oral solution (liquid) is more easily administered in emergency situations than pills, and is non-invasive. Patients also can continue on the same medication when they leave the hospital, which encourages long-term compliance. Dr. Currier adds that an oral-solution formulation offers benefits to caregivers as well. Injections expose staff members at hospitals and other facilities to an increased risk of needlepricks and a resultant exposure to diseases such as AIDS and hepatitis -- especially w
'"/>

Contact: John Gisborne
john.gisborne@ketchumcomms.co.uk
44-207-465-8753
Ketchum
10-Sep-2000


Page: 1 2 3

Related medicine news :

1. Newer formulation of heparin improves outcomes for suspected heart attack patients
2. Newer vitamin D formulation appears to help dialysis patients live longer
3. Bristol-Meyers Squibb submits NDA for new formulation of once daily videx(R)(didanosine)
4. Researchers warn antipsychotic drug
5. New antipsychotic drugs combined with nicotine patch help schizophrenics quit smoking
6. New study shows prescribing of newer antipsychotic medication risperdal may save millions in schizophrenia care
7. UCSF study offers insight into human circadian rhythms
8. Research offers hope of new treatments for liver damage
9. Portable system offers dialysis patients liberating changes
10. New laparoscopic hysterectomy offers quicker recovery time than traditional surgery
11. UIC offers new weight loss surgery for obese teens

Post Your Comments:
(Date:7/31/2014)... Thousands of independent community pharmacists, industry ... come together today to kick off ThoughtSpot 2014, ... "ThoughtSpot 2014 is Good Neighbor Pharmacy’s annual conference ... help their businesses thrive," stated AJ Caffentzis, President, ... commitment to independent community pharmacies, and at ThoughtSpot, ...
(Date:7/31/2014)... San Francisco, California (PRWEB) July 31, 2014 ... systems is expected to reach USD 37.83 billion ... Grand View Research, Inc. Increasing geriatric population base ... such as cardiovascular, orthopedic, and respiratory diseases coupled ... drive market growth over the next six years. ...
(Date:7/31/2014)... By Steven Reinberg ... (HealthDay News) -- Strict regulation of electronic cigarettes isn,t ... says. On the contrary, allowing e-cigarettes to compete ... the researchers concluded after reviewing 81 prior studies on ... "Current evidence suggests that there is a ...
(Date:7/31/2014)... (PRWEB) July 31, 2014 ... to reach $702m by 2020, increasing slowly ... market will be driven by: the rising ... incurred by government agencies, such as Medicare, ... adoption of innovative technologies such as flow ...
(Date:7/31/2014)... for those with periodontal disease related to type 2 diabetes, ... report appearing in the August 2014 issue of the ... most important blood cells involved in the human immune response, ... in type 2 diabetes-associated periodontal disease. These findings support ... cells may treat or prevent this complication. , "Our ...
Breaking Medicine News(10 mins):Health News:Good Neighbor Pharmacy’s ThoughtSpot Begins Today with Record Attendance 2Health News:Good Neighbor Pharmacy’s ThoughtSpot Begins Today with Record Attendance 3Health News:Medical Imaging Systems - Global Industry Trends, Size, Share, Opportunity, Growth, Outlook, Segmentation and Forecast from 2014 to 2020 - Grand View Research, Inc. 2Health News:Medical Imaging Systems - Global Industry Trends, Size, Share, Opportunity, Growth, Outlook, Segmentation and Forecast from 2014 to 2020 - Grand View Research, Inc. 3Health News:Medical Imaging Systems - Global Industry Trends, Size, Share, Opportunity, Growth, Outlook, Segmentation and Forecast from 2014 to 2020 - Grand View Research, Inc. 4Health News:Medical Imaging Systems - Global Industry Trends, Size, Share, Opportunity, Growth, Outlook, Segmentation and Forecast from 2014 to 2020 - Grand View Research, Inc. 5Health News:Medical Imaging Systems - Global Industry Trends, Size, Share, Opportunity, Growth, Outlook, Segmentation and Forecast from 2014 to 2020 - Grand View Research, Inc. 6Health News:Benefits of E-Cigarettes May Outweigh Harms, Study Finds 2Health News:Benefits of E-Cigarettes May Outweigh Harms, Study Finds 3Health News:US Neurovascular Interventions Market Worth $702m by 2020 Says a New Report Available at MarketOptimizer.org 2Health News:US Neurovascular Interventions Market Worth $702m by 2020 Says a New Report Available at MarketOptimizer.org 3Health News:US Neurovascular Interventions Market Worth $702m by 2020 Says a New Report Available at MarketOptimizer.org 4Health News:US Neurovascular Interventions Market Worth $702m by 2020 Says a New Report Available at MarketOptimizer.org 5Health News:Researchers uncover cause of gum disease related to type 2 diabetes 2
(Date:7/31/2014)... NOTTINGHAM, England , July 31, 2014 /PRNewswire/ ... ) today announced that its subsidiary, Molecular Profiles ... that will support pharmaceutical and biotech drug developers ... Profiles, pharmaceutical development services will be supported by ... (DMPK) to give clients a smarter route into ...
(Date:7/31/2014)... RESEARCH TRIANGLE PARK, N.C. , July 31, 2014 ... Miami facilities to meet the ... Latin America .  The newly expanded facility will ... biological samples, consolidation of shipments to and from the ... In its newest location, Marken will combine its ...
(Date:7/31/2014)... , July 31, 2014  Today,s Consumer Reports ... as an important reminder for consumers of the ... importance of initiatives such as the Acetaminophen Awareness ... consumer education campaign. Formed in 2010, the ... provider and consumer organizations dedicated to educating consumers ...
Breaking Medicine Technology:Columbia Laboratories' Subsidiary, Molecular Profiles, Strikes Alliance With Xenogesis 2Columbia Laboratories' Subsidiary, Molecular Profiles, Strikes Alliance With Xenogesis 3Marken Expands Miami Regional Logistics Center 2U.S. Health Coalition Calls for Continued Education on Acetaminophen, America's Most Common Drug Ingredient 2
Cached News: